{
    "Trade/Device Name(s)": [
        "BD Phoenix Automated Microbiology System",
        "BD Phoenix Automated Microbiology System - Tetracycline (0.0625-16 \u00b5g/mL) EY",
        "BD Phoenix Automated Microbiology System Tetracycline (0.0625-16 \u00b5g/mL) - Streptococcus ID/AST or AST only Phoenix Panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K050881",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "May 12, 2005",
    "Summary Letter Received Date": "April 7, 2005",
    "Submission Date": "April 5, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Tetracycline"
    ],
    "Specimen Type(s)": [
        "Pure culture of Gram-negative aerobic and facultative anaerobic bacteria",
        "Pure culture of Gram-positive bacteria (Staphylococcus, Enterococcus, Streptococcus)",
        "Streptococcus species including S. pneumoniae"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Redox indicator detection",
        "Automated antimicrobial susceptibility testing",
        "Continuous incubation"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing (AST)",
        "Minimal inhibitory concentration (MIC) determination",
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Reagent",
        "Instrument",
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System panels for tetracycline (0.0625-16 \u00b5g/mL) antimicrobial susceptibility testing of Streptococcus species.",
    "Indications for Use Summary": "Intended for rapid identification and quantitative determination of antimicrobial susceptibility by MIC of aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria, including Streptococcus species, using tetracycline at 0.0625-16 \u00b5g/mL on ID/AST or AST only Phoenix panels.",
    "fda_folder": "Microbiology"
}